These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6272925)

  • 1. Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole.
    Grigsby P; Maruyama Y
    Br J Radiol; 1981 Nov; 54(647):969-72. PubMed ID: 6272925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time dependence of interaction of misonidazole and WR-2721.
    Rojas A; Denekamp J
    Br J Radiol; 1983 Aug; 56(668):592-5. PubMed ID: 6307457
    [No Abstract]   [Full Text] [Related]  

  • 3. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
    Mendiondo OA; Connor AM; Grigsby P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioprotection combined with hypoxic sensitization during radiotherapy of a solid murine tumor.
    Mendiondo OA; Grigsby PW; Beach JL
    Radiology; 1983 Jul; 148(1):291-3. PubMed ID: 6304811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the radiation response of the mouse kidney by misonidazole and WR-2721.
    Williams MV; Denekamp J
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1731-6. PubMed ID: 6315650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioprotection of oral cavity structures by WR-2721.
    Utley JF; King R; Giansanti JS
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):643-7. PubMed ID: 213406
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of stromal radiosensitivity by misonidazole and WR-2721.
    Begg AC; Terry NH
    Br J Radiol; 1983 Aug; 56(668):565-70. PubMed ID: 6307455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1982 May; 45(5):684-93. PubMed ID: 6282299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Responses to radiation of Ehrlich ascites tumor cells in the presence of YM-08310 (=WR-2721) and/or Ro-07-0582 (in vivo, in vitro assay)].
    Ebe K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Feb; 47(2):307-17. PubMed ID: 3039456
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioprotective effect of WR-2721 in rabbits: a comparison with cystamine.
    Kuna P; Petýrek P; Jensovský V; Melek J
    Radiobiol Radiother (Berl); 1981; 22(5):644-52. PubMed ID: 6280232
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioprotective activity of ethylcellulose microspheres containing WR 2721, after oral administration.
    Fatome M; Courteille F; Laval JD; Roman V
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):21-9. PubMed ID: 3036725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradioprotection of the rat parotid gland by combined use of WR-2721 and Ro-07-0582.
    Sodicoff M; Conger AD; Pratt NE; Sinesi M; Trepper P
    Radiat Res; 1979 Nov; 80(2):348-53. PubMed ID: 228341
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of combined radiotherapy, hyperthermia, radioprotective agent and hypoxic cell sensitizer on mice testis--testicular weight as indicator of the combined effect].
    Nakano Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1152-66. PubMed ID: 3005960
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental radiotherapy with WR-2721 and misonidazole.
    Rojas A; Stewart FA; Denekamp J
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):527-30. PubMed ID: 6286547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of normal tissue against late radiation injury by WR-2721.
    Utley JF; Quinn CA; White FC; Seaver NA; Bloor CM
    Radiat Res; 1981 Feb; 85(2):408-15. PubMed ID: 6258191
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioprotection of mouse skin by WR-2721 in single and fractionated treatments.
    Stewart FA; Rojas A
    Br J Radiol; 1982 Jan; 55(649):42-7. PubMed ID: 6274467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of gammaphos (WR-2721) on survival in combined radiation injuries].
    Simović M; Erdeljan D; Pantelić D; Dekić M
    Vojnosanit Pregl; 1987; 44(2):99-106. PubMed ID: 3037790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.